Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Lunai Bioworks Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −4 vs. Q3 2022
- Shares held
- 3.63M
- −157.8K (−4.2%) vs. Q3 2022
- Total value
- $3.74M
- −$3.13M (−45.6%) vs. Q3 2022
- New holders
- 3
- 14 more added
- Sold out
- 7
- 13 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 1,077,241 | $1.11M | 0.00% | +34,830+3.3% | Added |
| Vanguard Group Inc | 758,703 | $781.5K | 0.00% | +3,540+0.5% | Added |
| Geode Capital Management, LLC | 318,783 | $328.0K | 0.00% | +1240.0% | Added |
| State Street Corp | 305,608 | $314.8K | 0.00% | −10,716−3.4% | Reduced |
| Northern Trust Corp | 161,216 | $166.1K | 0.00% | +11,680+7.8% | Added |
| Nuveen Asset Management, LLC | 124,577 | $128.0K | 0.00% | −16,582−11.7% | Reduced |
| Invesco Ltd. | 101,400 | $104.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 89,667 | $92.4K | 0.00% | −50,316−35.9% | Reduced |
| Two Sigma Advisers, LP | 78,100 | $80.4K | 0.00% | −33,100−29.8% | Reduced |
| Morgan Stanley | 71,340 | $73.5K | 0.00% | −77,568−52.1% | Reduced |
| Cantor Fitzgerald, L. P. | 59,724 | $62.0K | 0.00% | +13,814+30.1% | Added |
| Bank of New York Mellon Corp | 55,005 | $56.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 52,814 | $54.0K | 0.00% | +19,631+59.2% | Added |
| Charles Schwab Investment Management Inc | 50,951 | $52.5K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 46,467 | $47.9K | 0.00% | +133+0.3% | Added |
| Allspring Global Investments Holdings, LLC | 36,268 | $37.4K | 0.00% | −793−2.1% | Reduced |
| New York State Common Retirement Fund | 31,000 | $31.9K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 29,290 | $30.0K | 0.00% | +151+0.5% | Added |
| Blair William & Co | 26,000 | $26.8K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 23,654 | $24.4K | 0.00% | −4,013−14.5% | Reduced |
| Belvedere Trading LLC | 23,572 | $24.3K | 0.01% | +23,572 | New |
| AQR Capital Management LLC | 20,800 | $21.4K | 0.00% | −5,005−19.4% | Reduced |
| Dimensional Fund Advisors LP | 12,754 | $13.0K | 0.00% | −7,688−37.6% | Reduced |
| JPMorgan Chase & Co | 11,186 | $12.0K | 0.00% | +621+5.9% | Added |
| Alliancebernstein L.P. | 10,400 | $10.7K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 9,347 | $9.63K | 0.00% | −35−0.4% | Reduced |
| California State Teachers Retirement System | 7,889 | $8.13K | 0.00% | +89+1.1% | Added |
| Tower Research Capital LLC (TRC) | 7,680 | $8.00K | 0.00% | +3,196+71.3% | Added |
| UBS Group AG | 6,106 | $6.29K | 0.00% | +6,106 | New |
| BNP Paribas Arbitrage, SA | 5,429 | $5.59K | 0.00% | −3,748−40.8% | Reduced |
| Barclays PLC | 5,307 | $5.47K | 0.00% | +4,469+533.3% | Added |
| Amalgamated Bank | 4,279 | $4.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,296 | $3.00K | 0.00% | +3,054+1,262.0% | Added |
| Citigroup Inc | 1,902 | $1.96K | 0.00% | +1,602+534.0% | Added |
| Ameritas Investment Partners, Inc. | 1,482 | $1.85K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,653 | $1.70K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,289 | $1.33K | 0.00% | −501−28.0% | Reduced |
| Credit Suisse AG | 1 | $1 | 0.00% | −226−99.6% | Reduced |
| Citadel Advisors LLC | 1 | $1 | 0.00% | +1 | New |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −26,273−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −16,892−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −15,225−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −15,625−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Ellis Investment Partners, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |